Using AI to improve communication in prostate cancer treatment decisions
Natural Language Processing Based Consultation Feedback to Improve Patient Decision Making and Physician Risk Communication
['FUNDING_R01'] · CEDARS-SINAI MEDICAL CENTER · NIH-11050859
This study is testing a helpful tool that uses technology to make it easier for men with prostate cancer to understand their treatment options during doctor visits, so they can make better choices that fit their personal values and preferences.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CEDARS-SINAI MEDICAL CENTER (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-11050859 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the decision-making process for patients with prostate cancer by using a natural language processing (NLP) system. The system provides real-time feedback during consultations, helping both patients and physicians better understand the risks and benefits of various treatment options. By summarizing key points discussed in consultations, it aims to improve patient awareness and reduce confusion, ultimately leading to more informed decisions. The approach emphasizes shared decision-making, where patients are actively involved in choosing their treatment based on their values and preferences.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with prostate cancer who are facing treatment decisions.
Not a fit: Patients who are not diagnosed with prostate cancer or those who are not involved in treatment decision-making may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could empower patients with prostate cancer to make more informed treatment decisions, leading to better health outcomes.
How similar studies have performed: Previous research has shown that using technology to enhance communication in medical settings can improve patient understanding and decision-making, suggesting a promising avenue for this approach.
Where this research is happening
LOS ANGELES, UNITED STATES
- CEDARS-SINAI MEDICAL CENTER — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DASKIVICH, TIMOTHY — CEDARS-SINAI MEDICAL CENTER
- Study coordinator: DASKIVICH, TIMOTHY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Prognosis